Growth Metrics

Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2016 - 2026)

Zimmer Biomet Holdings has reported Cash from Investing Activities over the past 18 years, most recently at -$159.0 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 50.0% year-over-year to -$159.0 million; the TTM value through Mar 2026 reached -$2.0 billion, down 153.87%, while the annual FY2025 figure was -$2.0 billion, 122.46% down from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$159.0 million at Zimmer Biomet Holdings, up from -$322.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$81.1 million in Q1 2022 and troughed at -$1.4 billion in Q2 2025.
  • A 5-year average of -$254.3 million and a median of -$165.6 million in 2023 define the central range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 45.64% in 2025 and fell as far as 460.49% in 2025.
  • Year by year, Cash from Investing Activities stood at -$112.5 million in 2022, then plummeted by 96.27% to -$220.8 million in 2023, then plummeted by 31.88% to -$291.2 million in 2024, then fell by 10.58% to -$322.0 million in 2025, then soared by 50.62% to -$159.0 million in 2026.
  • Business Quant data shows Cash from Investing Activities for ZBH at -$159.0 million in Q1 2026, -$322.0 million in Q4 2025, and -$163.3 million in Q3 2025.